Insights On Upstream Manufacturing

  1. Maximizing Safety And Efficacy In Hematopoietic Stem Cell Manufacturing 7/28/2026

    See how automated, closed processing helps improve consistency in hematopoietic stem cell gene therapy manufacturing, supporting higher transduction efficiency and stronger preservation.

  2. Maximizing Safety And Efficacy In Hematopoietic Stem Cell Gene Therapy 7/28/2026

    Advances in automated stem cell engineering are improving gene transfer efficiency while maintaining cell quality, offering a path toward safer, more standardized, and scalable manufacturing workflows.

  3. Automated Ex Vivo Isolation, Transduction, And Expansion 7/28/2026

    An automated cell manufacturing workflow enables the isolation, expansion, and genetic modification of highly reactive immune cells, helping simplify production while supporting scalable development.

  4. Enrichment Of Human CD4+ And CD8+ Antigen-Specific T Cells 7/28/2026

    A fully automated workflow streamlines cell processing, labeling, and magnetic separation. Learn how automation supports reproducible manufacturing of virus- and cancer-targeted cellular products.

  5. Automated Manufacturing Of CD34-Enriched Cell Products 7/28/2026

    See how this streamlined approach produces high-quality CD34+ cell products from cryopreserved apheresis material, integrating thawing, washing, and enrichment into a single automated workflow.

  6. Ex-Vivo T Cell Depletion In Allogeneic HSCT 7/28/2026

    Explore a flexible cell depletion strategy that selectively removes targeted immune cell populations while preserving beneficial subsets, supporting tailored graft engineering approaches.

  7. Automated Tumor-Infiltrating Lymphocyte Expansion 7/28/2026

    Examine how automated TIL manufacturing supports consistent expansion of viable, tumor-reactive lymphocytes across multiple cancer types and production sites, helping address key scalability challenges.

  8. Automated Enrichment Of Human CD34+ Cells 7/28/2026

    Discover an automated strategy for enriching CD34+ cells, combining streamlined processing, strong purity and viability metrics, and reduced hands-on effort to support stem cell engineering.

  9. Automated Enrichment Of Human CD34+ Cells 7/28/2026

    Explore an automated approach to CD34+ cell enrichment that combines scalable processing and high-purity cell recovery, offering insight into performance metrics and practical considerations.

  10. Memory T Cells – Depletion Of CD45RA+ Cells 7/28/2026

    Learn how selective depletion of CD45RA-positive cells helps preserve pathogen-specific memory T cells, reduce potentially alloreactive populations, and support immune reconstitution strategies.